DekaBank Deutsche Girozentrale Portfolio holdings
AUM
$56.1B
1-Year Return
19.33%
This Quarter Return
+10.89%
1 Year Return
+19.33%
3 Year Return
+93.16%
5 Year Return
+155.59%
10 Year Return
+349.91%
AUM
$37.8B
AUM Growth
+$3.94B
(+12%)
Cap. Flow
+$1.45B
Cap. Flow
% of AUM
3.85%
Top 10 Holdings %
Top 10 Hldgs %
22%
Holding
1,437
New
65
Increased
570
Reduced
395
Closed
99
Top Buys
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$172M |
| 2 |
Amazon
AMZN
|
+$124M |
| 3 |
Automatic Data Processing
ADP
|
+$111M |
| 4 |
Apple
AAPL
|
+$109M |
| 5 |
UnitedHealth
UNH
|
+$96.9M |
Top Sells
| 1 |
Johnson & Johnson
JNJ
|
+$75.6M |
| 2 |
Linde
LIN
|
+$71.6M |
| 3 |
Sherwin-Williams
SHW
|
+$54.2M |
| 4 |
Cisco
CSCO
|
+$52.8M |
| 5 |
Medtronic
MDT
|
+$50M |
Sector Composition
| 1 | Technology | 23.8% |
| 2 | Healthcare | 19.83% |
| 3 | Financials | 11.79% |
| 4 | Industrials | 9.63% |
| 5 | Consumer Staples | 8.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1001
Coinbase
COIN
$81.9B
| $592K | ﹤0.01% |
17,230
+3,050
| +22% | +$105K |
|
1002
Douglas Emmett
DEI
$2.77B
| $576K | ﹤0.01% |
36,712
-5,317
| -13% | -$83.4K |
|
1003
Veracyte
VCYT
$2.55B
| $574K | ﹤0.01% |
24,200
| – | – |
|
1004
Twist Bioscience
TWST
$1.51B
| $573K | ﹤0.01% |
25,000
| – | – |
|
|
EQC
1005
DELISTED
Equity Commonwealth
EQC
| $573K | ﹤0.01% |
22,963
| – | – |
|
1006
Liberty Global Class A
LBTYA
$3.99B
| $569K | ﹤0.01% |
29,937
+2,378
| +9% | +$45.2K |
|
1007
Immunovant
IMVT
$2.85B
| $568K | ﹤0.01% |
32,600
| – | – |
|
1008
Arbutus Biopharma
ABUS
$784M
| $565K | ﹤0.01% |
250,000
| – | – |
|
1009
Kymera Therapeutics
KYMR
$3.11B
| $564K | ﹤0.01% |
22,000
| – | – |
|
1010
Revolution Medicines
RVMD
$7.68B
| $564K | ﹤0.01% |
23,800
| – | – |
|
1011
Park Hotels & Resorts
PK
$2.37B
| $563K | ﹤0.01% |
47,784
| – | – |
|
1012
Canadian Solar
CSIQ
$739M
| $553K | ﹤0.01% |
18,020
+2,964
| +20% | +$91K |
|
1013
Huntington Ingalls Industries
HII
$10.6B
| $551K | ﹤0.01% |
2,398
-1,503
| -39% | -$345K |
|
|
UNIT
1014
Uniti Group
UNIT
$1.79B
| $551K | ﹤0.01% |
98,600
| – | – |
|
1015
Mohawk Industries
MHK
$8.67B
| $546K | ﹤0.01% |
5,386
-10,699
| -67% | -$1.08M |
|
1016
Avidity Biosciences
RNA
$6.18B
| $544K | ﹤0.01% |
+24,000
| New | +$544K |
|
1017
Agios Pharmaceuticals
AGIO
$2.1B
| $542K | ﹤0.01% |
20,000
| – | – |
|
1018
Legend Biotech
LEGN
$6.39B
| $532K | ﹤0.01% |
10,734
-3,098
| -22% | -$154K |
|
1019
Cleveland-Cliffs
CLF
$5.35B
| $531K | ﹤0.01% |
32,479
+893
| +3% | +$14.6K |
|
1020
Summit Therapeutics
SMMT
$14B
| $531K | ﹤0.01% |
+100,000
| New | +$531K |
|
1021
Casey's General Stores
CASY
$19.4B
| $529K | ﹤0.01% |
2,339
| – | – |
|
1022
Shinhan Financial Group
SHG
$22.8B
| $529K | ﹤0.01% |
18,773
| – | – |
|
1023
Macerich
MAC
$4.68B
| $525K | ﹤0.01% |
47,529
| – | – |
|
1024
Reinsurance Group of America
RGA
$12.7B
| $523K | ﹤0.01% |
3,687
-293
| -7% | -$41.6K |
|
|
AKYA
1025
DELISTED
Akoya BioSciences
AKYA
| $522K | ﹤0.01% |
+55,000
| New | +$522K |
|